IPUMP Enhances Compliance in SLIT Treatment Stallergenes Greer, a global leader in allergy diagnostics and immunotherapy, has announced that it will present compelling findings from its SPEED survey at the upcoming Congrès Francophone d’Allergologie (CFA), the premier French-language congress for…
AdvanCell Announces $18M MRFF Funding for Targeted Prostate Cancer Therapy AdvanCell, a clinical-stage radiopharmaceutical company at the forefront of targeted cancer therapeutics, has received a significant boost from the Australian Federal Government. The company announced today that it has secured…
Vertex’s Paul Negulescu, Ph.D., Wins 2025 Gairdner Award for Cystic Fibrosis Breakthroughs In a landmark moment for both Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and the broader scientific community, Paul Negulescu, Ph.D., Senior Vice President at Vertex, has been named a…
Exicure Announces Plans for New Clinical Trial in Acute Myeloid Leukemia (AML) Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company focused on developing innovative therapeutics targeting diseases with high unmet medical needs, announced significant updates today regarding its lead investigational…
Signios Biosciences Unveils Rebrand and Expands Vision as a Leading Multiomics and AI Bioinformatics Innovator in Precision Medicine In a bold step forward reflecting its evolution and expanded capabilities, Signios Biosciences (formerly the U.S.-based research division of MedGenome Inc.) has…
Biologic Therapy Boosts Pregnancy Outcomes in High-Risk APS Patients Landmark Clinical Trial Finds Certolizumab Significantly Improves Pregnancy Outcomes in Women with Antiphospholipid Syndrome In a groundbreaking advancement for maternal-fetal medicine and autoimmune disease treatment, a phase 2 clinical trial co-led…
Textron Aviation Opens Second Plane Healthy Wellness Center & Pharmacy in Wichita to Enhance Employee Healthcare Access Textron Aviation Inc., a renowned aircraft manufacturer and a subsidiary of Textron Inc. (NYSE: TXT), has announced the opening of its second Plane…
Global Forecast: mRNA Vaccines & Therapeutics Market for Influenza, RSV, and CMV (2025) A new report titled “mRNA Vaccine and Therapeutics Market: Industry Trends and Global Forecasts to 2035 by Application Area, Target Disease Indication, and Geographical Regions” has been…
IBL International Partners with Grifols to Develop Cutting-Edge Biomarker Panels IBL International GmbH, a Tecan Group company renowned for its expertise in specialty diagnostics, has officially announced a strategic partnership with Grifols, a global healthcare leader with a legacy in…
Alpenglow Biosciences to Host AACR 2025 Dinner Talk on Spatial Biology in Endometrial Cancer Alpenglow Biosciences, a leading innovator in 3D spatial biology and digital pathology, is pleased to announce its exclusive Dinner Lecture during the American Association for Cancer…
Sail Biomedicines Welcomes Dr. Laura Sepp-Lorenzino to Its Board of Directors Sail Biomedicines, Inc., a pioneering biotechnology company at the forefront of programmable RNA-based medicines and a Flagship Pioneering-founded enterprise, today announced the appointment of Laura Sepp-Lorenzino, Ph.D., to its…
Hello Heart Launches Smart Pill Box to Transform Medication Adherence In a significant step forward for digital heart health management, Hello Heart, the leading digital platform for preventive heart care, has announced the release of its latest innovation: the Hello…